Granules receives Health Canada nod for arthritis tablets
The drug will be manufactured at the Granules manufacturing facility located at Gagillapur, Hyderabad.
Hyderabad: Hyderabad-based Granules India said it received marketing approval from Health Canada for Acetaminophen Extended-Release Tablets OTC, 650mg for the treatment of arthritis pain.
The drug will be manufactured at the Granules manufacturing facility located at Gagillapur, Hyderabad. The product is a bioequivalent to the reference listed drug, Tylenol Extended Release 650 Tablets.
Priyanka Chigurupati, ED, Granules USA & Granules Pharmaceuticals, said, “We received the approval within eight months of filing. This is a step towards global expansion of our core molecules. The approval of Acetaminophen Extended-Release Tablets OTC, 650mg, a complex Bi-layer Extended Released based formulation, is a good addition to our portfolio. We will be launching the product in the Canada market soon.”
Granules now have a total of two ANDS (abbreviated new drug submissions) approvals from Health Canada.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .
